Abdominal malignancies missed during laparoscopic cholecystectomy

Wysocki, A; Lejman, W; Bobrzyński, A

doi:10.1007/s004640090022

Cited by 14 publications

(9 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Some studies have shown that a not uncommon cause of readmission after laparoscopic cholecystectomy is colon cancer [18,97,98] . As such, all short term studies which did not adjust for the period between cholecystectomy and the incident cancer must be Todoroki et al [67] , 1999 1991-1994 1 Ekbom et al [68] , 1993 1965-1983 viewed with caution.…”

Section: Discussionmentioning

confidence: 99%

Cholecystectomy and the risk of alimentary tract cancers: A systematic review

Coats

Shimi

2015

WJG

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Cholecystectomy and the risk of alimentary tract cancers: A systematic review

Coats

Shimi

2015

WJG

View full text Add to dashboard Cite

show abstract

“…It is well established that early manifestations of abdominal cancer are sometimes misdiagnosed as gallstones and treated with cholecystectomy. For example, recent studies have shown that, of patients readmitted within a few months of laparoscopic cholecystectomy, a common cause of readmission is colon cancer (Gal et al, 1998;Malouf et al, 2000;Wysocki et al, 2001).…”

Section: Discussionmentioning

confidence: 99%

Cancer after cholecystectomy: record-linkage cohort study

et al. 2005

View full text Add to dashboard Cite

We investigated whether cholecystectomy is associated with subsequent cancer and, if so, whether the association is likely to be causal, by undertaking a retrospective cohort study using linked medical statistics, comprising a cholecystectomy group (n ¼ 39 254) and a reference cohort admitted for a range of other medical and surgical conditions (n ¼ 334 813). We found a short-term significant elevation of rates of cancers of the colon, pancreas, liver, and stomach after cholecystectomy, but no long-term elevation. Excluding colon cancers within 2 years of admission to hospital, the rate ratio for colon cancer after cholecystecomy, compared with the reference cohort, was 1.01 (95% confidence interval 0.90 -1.12) and after 10 years or more follow-up it was 0.94 (0.79 -1.10). It is highly improbable that the short-term associations between cholecystectomy and gastrointestinal cancers are causal, and we conclude that cholecystectomy does not cause cancer.

show abstract

“…Nevertheless, ovarian involvement has been indicated in case reports describing patients with hepatocellular carcinoma (Oortman and Elliott, 1983;Young et al, 1992a, b;de Groot et al, 2000;Stippel et al, 2005;Montero et al, 2007;Lee et al, 2011;Benito et al, 2012), hepatoblastoma (Green and Silva, 1989) and bile duct or gallbladder carcinomas (Lashgari et al, 1992;Petru et al, 1992;Chang et al, 1997;Ayhan et al, 2001;Low et al, 2003;Miyagui et al, 2003;Garcia et al, 2004;Jain et al, 2006;Khunamornpong et al, 2007Khunamornpong et al, , 2008Lee et al, 2009;Kumar et al, 2010;Singh et al, 2010;Pusiol et al, 2011). Tumours of the small bowel and pancreatic tumours were also shown to have the capacity to metastasize to the ovaries (Roley et al, 1990;Tsuruchi et al, 1995;Loke et al, 1997;Dunsmore and Lovell, 1998;Wysocki et al, 2001;Yanai et al, 2003;Ayhan et al, 2005;Husain et al, 2006;Maekawa et al, 2010).…”

Section: Other Tumours Of the Gastrointestinal Tractmentioning

confidence: 99%

Autotransplantation of cryopreserved ovarian tissue in cancer survivors and the risk of reintroducing malignancy: a systematic review

Bastings

Beerendonk

Westphal

et al. 2013

Human Reproduction Update

193

105

View full text Add to dashboard Cite

BACKGROUND The risk of recurrent oncological disease due to the reintroduction of cancer cells via autotransplantation of cryopreserved ovarian tissue is unknown. METHODS A systematic review of literature derived from MEDLINE, EMBASE and the Cochrane Library was conducted. Studies on follow-up after autotransplantation; detection of cancer cells in ovarian tissue from oncological patients by histology, polymerase chain reaction or xenotransplantation; and epidemiological data on ovarian metastases were included. RESULTS A total of 289 studies were included. Metastases were repeatedly detected in ovarian tissue obtained for cryopreservation purposes from patients with leukaemia, as well as in one patient with Ewing sarcoma. No metastases were detected in ovarian tissue from lymphoma and breast cancer patients who had their ovarian tissue cryopreserved. Clinical studies indicated that one should be concerned about autotransplantation safety in patients with colorectal, gastric and endometrial cancer. For patients with low-stage cervical carcinoma, clinical data were relatively reassuring, but studies focused on the detection of metastases were scarce. Oncological recurrence has been described in one survivor of cervical cancer and one survivor of breast cancer who had their ovarian tissue autotransplanted, although these recurrences may not be related to the transplantation. CONCLUSIONS It is advisable to refrain from ovarian tissue autotransplantation in survivors of leukaemia. With survivors of all other malignancies, current knowledge regarding the safety of autotransplantation should be discussed. The most reassuring data regarding autotransplantation safety were found for lymphoma patients.

show abstract

Abdominal malignancies missed during laparoscopic cholecystectomy

Cited by 14 publications

References 14 publications

Cholecystectomy and the risk of alimentary tract cancers: A systematic review

Cholecystectomy and the risk of alimentary tract cancers: A systematic review

Cancer after cholecystectomy: record-linkage cohort study

Autotransplantation of cryopreserved ovarian tissue in cancer survivors and the risk of reintroducing malignancy: a systematic review

Contact Info

Product

Resources

About